Targeting non-coding RNA for the therapy of renal disease
1Centre for Cardiovascular Sciences, College of Medicine and Veterinary Medicine, University of Edinburgh, UK.
Abstract:
MicroRNAs (miRNA) are small non-coding RNA molecules representing a novel class of endogenous negative regulators of gene expression. MiRNA have the ability to bind to specific regions in the 3'UTR of mRNA and repress gene expression through interaction with the RNA induced silencing complex (RISC). They have now been implicated in the pathophysiology of many kidney diseases, including the onset and progression of tubulointerstitial and glomerulosclerosis and have potential as biomarkers and as novel targets for treatment. The unique feature of miRNAs to target multiple mRNAs defines that targeting a particular miRNA for therapy could have a dramatic effect on the disease process. This review will focus on our current understanding of the role of miRNA in renal diseases, including diabetes, renal fibrosis, IgA nephropathy and explore the miRNA targets which represent the most promising in terms of clinical translation.
Insights
MicroRNAs regulate gene expression and are involved in kidney diseases like diabetes and fibrosis. Targeting specific microRNAs offers promising therapeutic strategies for renal conditions.
Area of Science:
- Molecular Biology
- Genetics
- Nephrology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
- miRNAs function by binding to mRNA targets, influencing protein production.
- They are implicated in the pathophysiology of various kidney diseases.
Purpose of the Study:
- To review the current understanding of miRNA roles in renal diseases.
- To explore potential miRNA biomarkers for kidney conditions.
- To identify promising miRNA targets for therapeutic intervention.
Main Methods:
- Literature review of studies on miRNAs in kidney diseases.
- Analysis of miRNA involvement in diabetes, renal fibrosis, and IgA nephropathy.
- Evaluation of miRNA targets for clinical translation.
Main Results:
- miRNAs play a significant role in the onset and progression of kidney diseases.
- Specific miRNAs are associated with tubulointerstitial and glomerulosclerosis.
- Multiple mRNA targets of a single miRNA suggest significant therapeutic potential.
Conclusions:
- miRNAs are key players in renal pathophysiology.
- Targeting miRNAs presents a novel therapeutic avenue for kidney diseases.
- Further research into miRNA targets could lead to effective clinical treatments.
More Related Videos
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of RNA
RNA Performs Diverse...


